ARCHIVES

Oncologists Don’t Demand Increased Survival When Ordering Expensive Drugs, Survey Finds

This article is from The Cancer Letter archive.

Vol. 38 No. 15 | April 13, 2012

Download PDF Visit The Full Archive

Related Articles

NCI Developing Policy On Relations Between Industry, DCT Clinical Trials

July 29, 1983

Worker Health RFA May Finally Be Ready

August 26, 1988

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002

Smoking Intensity and Markers Predict Cancer Aggressiveness

January 25, 2013

In Brief: ACS Estimates 502,000 U.S. Cancer Deaths, 178,000 Avoidable With Early Diagnosis

March 17, 1989

ODAC Recommends Approval of Evista for Breast Cancer Risk Reduction.

July 27, 2007